Sequence: WEAHLAHALAHALARHLARALARALRACEA
| Experiment Id | EXP000193 |
|---|---|
| Paper | Development and Characterization of High Efficacy Cell-Penetrating Peptide via Modulation of the His |
| Peptide | HALA3 |
| Delivery Success Class | no |
| In Vivo Flag | no |
| Uptake Confirmed | yes |
| Label Confidence | high |
| In Vitro Functional Effect | yes |
| Endosomal Escape Evidence | |
| Peptide Concentration | |
| Rna Concentration | |
| Mixing Ratio | |
| Formulation Format | Non-covalent peptide–nucleic acid nanocomplex |
| Formulation Components | <200 nm |
| Size Nm | |
| Zeta Mv | 25.00 |
| Model Scope | in_vitro |
| Model Type | in vitro |
| Cell Lines Or Primary Cells | HeLa; HEK-293T; A549 |
| Animal Model | |
| Administration Route | |
| Output Type | transfection / gene silencing |
| Output Value | |
| Output Units | |
| Output Notes | HALA2 shows highest pDNA expression and GAPDH silencing; others moderate |
| Toxicity Notes | |
| Curation Notes |